company-logo

Recce Pharmaceuticals Ltd, a biotechnology company, engages in the research, development, and commercialization of synthetic anti–infectives in Australia, the United States, and the United Kingdom. The company's lead candidate is RECCE 327 to treat blood infections and sepsis derived from E. coli and S. aureus bacteria, including their superbug forms. It also develops RECCE 529, a synthetic anti-infective for viral infections; and RECCE 435, a synthetic polymer anti-infective. The company was formerly known as Recce Limited and changed its name to Recce Pharmaceuticals Ltd in November 2017. Recce Pharmaceuticals Ltd was incorporated in 2007 and is headquartered in Sydney, Australia.

Recce Pharmaceuticals Dividend Announcement

Recce Pharmaceuticals does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
Stay tuned for updates on Recce Pharmaceuticals dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Recce Pharmaceuticals Dividend History

Recce Pharmaceuticals Dividend Yield

Recce Pharmaceuticals current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Recce Pharmaceuticals stock? Use our calculator to estimate your expected dividend yield:

Recce Pharmaceuticals Financial Ratios

P/E ratio-5.37
PEG ratio-0.05
P/B ratio-9.96
ROE392.94%
Payout ratio0.00%
Current ratio0.34
Quick ratio0.34
Cash Ratio0.29

Recce Pharmaceuticals Dividend FAQ

Does Recce Pharmaceuticals stock pay dividends?
Recce Pharmaceuticals does not currently pay dividends to its shareholders.
Has Recce Pharmaceuticals ever paid a dividend?
No, Recce Pharmaceuticals has no a history of paying dividends to its shareholders. Recce Pharmaceuticals is not known for its dividend payments.
Why doesn't Recce Pharmaceuticals pay dividends?
There are several potential reasons why Recce Pharmaceuticals would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Recce Pharmaceuticals ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Recce Pharmaceuticals has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Recce Pharmaceuticals a dividend aristocrat?
Recce Pharmaceuticals is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Recce Pharmaceuticals a dividend king?
Recce Pharmaceuticals is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Recce Pharmaceuticals a dividend stock?
No, Recce Pharmaceuticals is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Recce Pharmaceuticals stocks?
To buy Recce Pharmaceuticals you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Recce Pharmaceuticals stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.